Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
GEN Roundup: Multiplex Immunoassays Bring the Array, Not the Disarray
Get Multiplex Immunoassay Advice from GEN's Expert Panel
Search Results for
Takeda, Noile-Immune Sign CAR-T Therapy Deal
September 6, 2017
GEN News Highlights More » September 6, 2017 Takeda, Noile-Immune Sign CAR-T Therapy Deal Takeda Pharmaceutical inked a collaboration agreement with Tokyo-based Noile-Immune ...
Takeda to Codevelop AstraZeneca's Clinic-Bound Parkinson's Candidate...
August 29, 2017
GEN News Highlights More » August 29, 2017 Takeda to Codevelop AstraZeneca's Clinic-Bound Parkinson's Candidate MEDI1341 Alex Philippidis Takeda Pharmaceutical will partner with ...
Top Eight Asia Biopharma Clusters 2017
June 30, 2017
... One of the year's biggest deals came in February, when Takeda Pharma completed its $5.2 billion acquisition of ARIAD Pharmaceuticals. Also in February, home-grown Asahi Glass ...
BE Licenses Takeda's Measles and Pertussis Vaccines for India...
June 26, 2017
Biological E. (BE) negotiated two licensing agreements with Takeda for the latter's ... Takeda has sold both the vaccines in Japan for more than 20 years. The agreements give ...
Numerate to Use AI Platform in Developing Drugs for Takeda |...
June 12, 2017
Takeda Computational drug design company Numerate said today it will use its artificial intelligence (AI) platform to identify and deliver multiple clinical candidates for Takeda ...
Takeda Negotiates Right to Buy GammaDelta for T-Cell Immunotherapeutic...
May 9, 2017
GEN News Highlights More » May 9, 2017 Takeda Negotiates Right to Buy GammaDelta for T-Cell Immunotherapeutics Platform Takeda has negotiated an exclusive right to acquire ...
Wearables Add Value to Clinical Trials
May 1, 2017
In late February, CognitionKit (a joint venture between Cambridge Cognition and Ctrl Group) partnered with Takeda Pharmaceuticals USA to evaluate how well a wearable technology ...
Takeda, Harrington Discovery Institute Launch Rare Disease Collaborati...
April 27, 2017
GEN News Highlights More » April 27, 2017 Takeda, Harrington Discovery Institute Launch Rare Disease Collaboration Takeda Pharmaceutical will partner with Harrington Discovery ...
Takeda Slicing Ariad Workforce After Acquisition
March 30, 2017
GEN News Highlights More » March 30, 2017 Takeda Slicing Ariad Workforce After Acquisition Takeda Pharmaceutical has absorbed only part of the nearly 300-employee workforce it ...
Icahn Names Gene Transfer Pioneer as Portfolio Manager
March 3, 2017
M.D., into retirement from the helm of Ariad Pharmaceuticals, the cancer drug developer that he founded in 1991 and is being acquired by Takeda Pharmaceutical for $5.2 billion. Dr. ...